当前位置： SCI文献检索 > EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING期刊下所有文献 > PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

Abstract：

PURPOSE:Salvage of young patients with follicular lymphoma (FL) after R-CHOP includes salvage immunochemotherapy followed by autologous stem cell transplantation (ASCT). Previous studies dealing with relapsed Hodgkin lymphoma have shown the prognostic value of PET/CT prior to ASCT. METHODS:We retrospectively analysed 59 patients with refractory/relapsed FL after first-line R-CHOP who were chemosensitive (as evaluated by CT) to the salvage treatment and who proceeded to ASCT. The role of PET/CT in this setting to define chemosensitivity is not definitely established. So we focused on the prognostic value of PET/CT performed after salvage treatment, before ASCT. RESULTS:The estimated 3-year progression-free survival (PFS) and overall survival were 63.1% (50.9-78.3%) and 90.5% (82.8 - 98.8%), respectively, and did not differ significantly according to their Follicular Lymphoma International Prognostic Index at relapse, conditioning regimen, or type of salvage. PFS was significantly lower in PET/CT-positive patients, according to the International Harmonization Project revised response criteria, with a 3-year PFS of 45.5% (26.6 - 77.8%) versus 72.6% (58.5 - 90.0%; p = 0.039). To better refine prognosis, we applied two types of throsholds: a Deauville five-point scale positive threshold of ≥3 (3-year PFS of 74.9%, range 61.0 - 92.1% %, versus 42.8%, range 24.7 - 74.4%; p = 0.02), and a ≥70% ∆SUVmax threshold between presalvage and pre-ASCT PET/CT (3-year PFS of 72.4%, range 57.5 - 91.3% versus 13.3%, 2.2 - 81.7%; p < 10(-3)). The PET/CT findings before ASCT were independently correlated with PFS in our series. CONCLUSION:PET/CT negativity before ASCT is a desirable and achievable goal in the management of chemosensitive FL relapsing after first-line R-CHOP.

journal_name

Eur J Nucl Med Mol Imaging

journal_title

European journal of nuclear medicine and molecular imaging

authors

Alcantara M,Dupuis J,Mareschal S,Julian A,Cottereau AS,Becker S,Dubois S,Oberic L,Huynh A,Meignan M,Laurent G,Tilly H,Haioun C,Ysebaert L

doi

10.1007/s00259-014-2896-2

subject

Has Abstract

pub_date

2015-02-01 00:00:00

pages

215-21

issue

2

eissn

1619-7070

issn

1619-7089

journal_volume

42

pub_type

杂志文章

相关文献

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING文献大全
  • Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer.

    abstract：PURPOSE:Diagnostic imaging modalities have moderate sensitivity for the identification of lymph node (LN) metastases in prostate cancer (PCa) patients. Mapping the lymphatic drainage from the prostate can help to identify the LNs directly draining from the tumour (sentinel nodes (SNs)); the LNs stated to have the highe...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-019-04443-z

    authors： de Korne CM,Wit EM,de Jong J,Valdés Olmos RA,Buckle T,van Leeuwen FWB,van der Poel HG

    更新日期：2019-11-01 00:00:00

  • Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.

    abstract：PURPOSE:Brain serotonin 6 receptor (5-HT6) is one of the most recently identified serotonin receptors. It is a potent therapeutic target for psychiatric and neurological diseases, e.g. schizophrenia and Alzheimer's disease. Since no specific fluorinated radioligand has yet been successfully used to study this receptor ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-014-2936-y

    authors： Becker G,Colomb J,Sgambato-Faure V,Tremblay L,Billard T,Zimmer L

    更新日期：2015-03-01 00:00:00

  • Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.

    abstract：:We evaluated an autoradiographic (ARG) method to calculate regional cerebral blood flow (rCBF) sequentially before and after an acetazolamide (ACZ) challenge in a single session of single-photon emission tomography (SPET) with two injections of N-isopropyl-[(123)I] p-iodoamphetamine (IMP). The method uses a table look...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-003-1180-7

    authors： Nishizawa S,Iida H,Tsuchida T,Ito H,Konishi J,Yonekura Y

    更新日期：2003-07-01 00:00:00

  • Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.

    abstract：PURPOSE:The dopamine transporter (DAT) is a plasma membrane protein of central interest in the pathophysiology of neuropsychiatric disorders and is known to be a target for psychostimulant drugs. [(11)C]PE2I is a new radioligand which binds selectively and with moderate affinity to central DAT, as has been demonstrated...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-005-0027-9

    authors： Jucaite A,Odano I,Olsson H,Pauli S,Halldin C,Farde L

    更新日期：2006-06-01 00:00:00

  • Cardiac 82Rubidium PET/CT: initial European experience.

    abstract：PURPOSE:Myocardial perfusion with PET/CT has advantages over conventional SPECT. We describe our initial European experience using (82)Rubidium-PET/CT, as part of a clinical myocardial perfusion service. METHODS:We studied the first 100 patients (64 male; 36 female, mean age = 60: SD +/-12.5y, mean body mass index = 3...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-007-0537-8

    authors： Groves AM,Speechly-Dick ME,Dickson JC,Kayani I,Endozo R,Blanchard P,Shastry M,Prvulovich E,Waddington WA,Ben-Haim S,Bomanji JB,McEwan JR,Ell PJ

    更新日期：2007-12-01 00:00:00

  • TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.

    abstract：OBJECTIVE:The 18-kDa mitochondrial translocator protein (TSPO) was reported to be upregulated in gliomas. 18F-GE-180 is a novel 3rd generation TSPO receptor ligand with improved target-to-background contrast compared to previous tracers. In this pilot study, we compared PET imaging with 18F-GE-180 and MRI of patients w...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3799-9

    authors： Albert NL,Unterrainer M,Fleischmann DF,Lindner S,Vettermann F,Brunegraf A,Vomacka L,Brendel M,Wenter V,Wetzel C,Rupprecht R,Tonn JC,Belka C,Bartenstein P,Niyazi M

    更新日期：2017-12-01 00:00:00

  • Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?

    abstract：PURPOSE:Alzheimer's disease (AD) is a primary degenerative disease that progressively affects all brain functions, with devastating consequences for the patient, the patient's family and society. Rest regional cerebral blood flow (rCBF) could have a strategic role in differentiating between AD patients and normal contr...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-005-1874-0

    authors： Sundström T,Elgh E,Larsson A,Näsman B,Nyberg L,Riklund KA

    更新日期：2006-01-01 00:00:00

  • Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.

    abstract：PURPOSE:Poor liver tumor visibility after microwave ablation (MWA) limits direct tumor ablation margin assessments using contrast-enhanced CT or ultrasound (US). Positron emission tomography (PET) or PET/CT may offer improved intraprocedural assessment of liver tumor ablation margins versus current imaging techniques, ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-05104-2

    authors： Yan Z,Khorasani R,Levesque VM,Gerbaudo VH,Shyn PB

    更新日期：2020-11-11 00:00:00

  • Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.

    abstract：PURPOSE:The purpose of this study was to evaluate the impact of [18F]fluorodeoxy-D-glucose positron emission tomography (FDG-PET) on the primary staging of patients with small-cell lung cancer (SCLC). METHODS:FDG-PET was performed in 120 consecutive patients with SCLC during primary staging. In addition, brain examina...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-004-1606-x

    authors： Brink I,Schumacher T,Mix M,Ruhland S,Stoelben E,Digel W,Henke M,Ghanem N,Moser E,Nitzsche EU

    更新日期：2004-12-01 00:00:00

  • Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

    abstract：PURPOSE:Interim 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) has shown to be an accurate predictor of prognosis in Hodgkin's lymphoma (HL). However, FDG PET response criteria are a matter of ongoing debate. The aim of this study was to confirm the prognostic value of interim PET/CT in HL pat...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-011-1741-0

    authors： Le Roux PY,Gastinne T,Le Gouill S,Nowak E,Bodet-Milin C,Querellou S,Mahe B,Dubruille V,Blin N,Salaun PY,Bodere-Kraeber F

    更新日期：2011-06-01 00:00:00

  • Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications.

    abstract：:Techniques from the field of artificial intelligence, and more specifically machine (deep) learning methods, have been core components of most recent developments in the field of medical imaging. They are already being exploited or are being considered to tackle most tasks, including image reconstruction, processing (...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-019-04373-w

    authors： Visvikis D,Cheze Le Rest C,Jaouen V,Hatt M

    更新日期：2019-12-01 00:00:00

  • Highlights of the European Association of Nuclear Medicine Congress, Athens, Greece, 30 September to 4 October 2006.

    abstract：:The 2006 EANM Congress, held in Athens, Greece, was once again a major event in the nuclear medicine scientific and educational calendar. The scientific programme, which included the second biennial ISRTRD meeting, confirmed the major developments taking place in (1) the diagnostic and prognostic uses of nuclear medic...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type：

    doi：10.1007/s00259-006-0327-8

    authors： McKillop JH,Martin-Comin J,Knapp FF Jr,Britten AJ

    更新日期：2007-02-01 00:00:00

  • Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation.

    abstract：INTRODUCTION:Somatostatin receptor imaging with PET is the standard of care for patients with a neuroendocrine tumour (NET). Since therapy and imaging with somatostatin analogues utilize the same receptor, current guidelines recommend withdrawing long-acting somatostatin analogues for 3-4 weeks prior to somatostatin re...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-018-4117-x

    authors： Aalbersberg EA,de Wit-van der Veen BJ,Versleijen MWJ,Saveur LJ,Valk GD,Tesselaar MET,Stokkel MPM

    更新日期：2019-03-01 00:00:00

  • Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.

    abstract：:Paragangliomas or glomus tumours of the head and neck region are rare somatostatin receptor-expressing neuroendocrine tumours. Precise preoperative diagnosis is of special importance in order to adequately weigh the potential benefit of the operation against the inherent risks of the procedure. In this study, the clin...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-002-0939-6

    authors： Schmidt M,Fischer E,Dietlein M,Michel O,Weber K,Moka D,Stennert E,Schicha H

    更新日期：2002-12-01 00:00:00

  • Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

    abstract：:The last 25 years have seen major changes in the imaging investigation and subsequent management of patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL); accurate staging is vital for prognostication and treatment in both, and particularly in HD. The choice of imaging modality for staging depends on i...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-003-1159-4

    authors： Vinnicombe SJ,Reznek RH

    更新日期：2003-06-01 00:00:00

  • Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer.

    abstract：:In prostate cancer, confirmation of metastatic involvement of the skeleton has traditionally been achieved by bone scintigraphy, although the widespread availability of prostate-specific antigen (PSA) measurements has tended to eliminate the need for this investigation. The potential of bone scintigraphy to predict sk...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-004-1479-z

    authors： Soerdjbalie-Maikoe V,Pelger RC,Lycklama à Nijeholt GA,Arndt JW,Zwinderman AH,Bril H,Papapoulos SE,Hamdy NA

    更新日期：2004-07-01 00:00:00

  • Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc-HMPAO SPET brain images.

    abstract：:Vagus nerve stimulation (VNS) has gained recognition as a treatment for refractory epilepsies where surgical treatment is not possible. While it appears that this treatment is effective in some patients, the mechanism of action is not clearly understood. The purpose of this study was to clarify findings of other posit...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-002-1026-8

    authors： Barnes A,Duncan R,Chisholm JA,Lindsay K,Patterson J,Wyper D

    更新日期：2003-02-01 00:00:00

  • The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients.

    abstract：OBJECTIVE:When deciding on therapy, FDG PET/CT-positive results should be confirmed by histology if possible. We evaluated the impact of percutaneous PET/CT-guided biopsies on histological confirmation of PET/CT-positive lesions. METHODS:We prospectively evaluated 126 patients who had undergone a PET/CT scan with posi...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-012-2263-0

    authors： Cerci JJ,Pereira Neto CC,Krauzer C,Sakamoto DG,Vitola JV

    更新日期：2013-01-01 00:00:00

  • Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.

    abstract：PURPOSE:PET has been proven to be helpful in the delineation of gross tumour volume (GTV) for external radiation therapy in several tumour entities. The aim of this study was to determine if [(11)C]choline PET could be used to localize the carcinomatous tissue within the prostate in order to specifically target this ar...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-013-2345-7

    authors： Bundschuh RA,Wendl CM,Weirich G,Eiber M,Souvatzoglou M,Treiber U,Kübler H,Maurer T,Gschwend JE,Geinitz H,Grosu AL,Ziegler SI,Krause BJ

    更新日期：2013-06-01 00:00:00

  • Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.

    abstract：:Radiomics in nuclear medicine is rapidly expanding. Reproducibility of radiomics studies in multicentre settings is an important criterion for clinical translation. We therefore performed a meta-analysis to investigate reproducibility of radiomics biomarkers in PET imaging and to obtain quantitative information regard...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-019-04391-8

    authors： Zwanenburg A

    更新日期：2019-12-01 00:00:00

  • Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants.

    abstract：PURPOSE:To assess the binding of the PET tracer [18F]THK5351 in patients with different primary progressive aphasia (PPA) variants and its correlation with clinical deficits. The majority of patients with nonfluent variant (NFV) and logopenic variant (LV) PPA have underlying tauopathy of the frontotemporal lobar or Alz...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-018-4075-3

    authors： Schaeverbeke J,Evenepoel C,Declercq L,Gabel S,Meersmans K,Bruffaerts R,Adamczuk K,Dries E,Van Bouwel K,Sieben A,Pijnenburg Y,Peeters R,Bormans G,Van Laere K,Koole M,Dupont P,Vandenberghe R

    更新日期：2018-12-01 00:00:00

  • Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.

    abstract：PURPOSE:The aim of this study was to investigate the feasibility of assessing dopamine transporter binding after treatment with methylphenidate in the rat using a recently developed high-resolution small animal single-photon emission computed tomograph (TierSPECT) and [123I]FP-CIT. METHODS:[123I]FP-CIT was administere...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-004-1615-9

    authors： Nikolaus S,Wirrwar A,Antke C,Arkian S,Schramm N,Müller HW,Larisch R

    更新日期：2005-03-01 00:00:00

  • Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.

    abstract：PURPOSE:Diffusion-weighted magnetic resonance imaging (DWI) and fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) are oncological feasible techniques. Currently, apparent diffusion coefficient (ADC) measured by DWI and standard uptake value (SUV) from FDG PET/CT have similar applications ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-008-0936-5

    authors： Ho KC,Lin G,Wang JJ,Lai CH,Chang CJ,Yen TC

    更新日期：2009-02-01 00:00:00

  • Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.

    abstract：PURPOSE:Although two norepinephrine transporter (NET) radioligands, (S,S)-[(18)F]FMeNER-D(2) and (S,S)-[(11)C]MeNER, have been reported to have different characteristics, there has not been a direct comparative study in vivo. METHODS:In this preliminary study, two rhesus monkeys underwent three PET measurements each, ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-009-1194-x

    authors： Takano A,Gulyás B,Varrone A,Halldin C

    更新日期：2009-11-01 00:00:00

  • Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates-new perspectives for folate receptor-targeted radionuclide therapy.

    abstract：PURPOSE:The folate receptor (FR) is frequently overexpressed in a variety of tumor types and, hence, an interesting target for radionuclide therapy. The aim of this study was to evaluate a new class of albumin-binding radioconjugates comprising 5-methyltetrahydrofolate (5-MTHF) as a targeting agent and to compare their...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-04980-y

    authors： Guzik P,Benešová M,Ratz M,Monné Rodríguez JM,Deberle LM,Schibli R,Müller C

    更新日期：2020-10-15 00:00:00

  • 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.

    abstract：PURPOSE:The purpose of this prospective study was to evaluate the usefulness of (18)F-fluorodeoxyglucose (FDG) and (11)C-choline positron emission tomography (PET)/computed tomography (CT) for detecting recurrences of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy. Additionall...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-010-1400-x

    authors： Ito K,Yokoyama J,Kubota K,Morooka M,Shiibashi M,Matsuda H

    更新日期：2010-07-01 00:00:00

  • Model-based comparison of maternal and foetal organ doses from (99m)Tc pertechnetate, DMSA, DTPA, HDP, MAA and MAG(3) diagnostic intakes during pregnancy.

    abstract：:Organ residence times were calculated for diagnostic intakes of (99m)Tc pertechnetate, 2,3-dimercaptosuccinic acid (DMSA), diethylene triamine penta-acetic acid (DTPA), hydroxymethylene diphosphonate (HDP), macroaggregated albumin (MAA) and mercapto-acetyltriglycine (MAG(3)) during the 1st and 3rd stages of pregnancy ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-002-0858-6

    authors： Saunders M,Palmer M,Preece A,Millard R

    更新日期：2002-10-01 00:00:00

  • Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT.

    abstract：PURPOSE:The specific binding ratio (SBR) of 123I-FP-CIT (FP-CIT) in the putamen decreases with age by about 5% per decade and most likely is about 10% higher in females. However, the clinical utility of age and sex correction of the SBR is still a matter of debate. This study tested the impact of age and sex correction...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-05085-2

    authors： Schmitz-Steinkrüger H,Lange C,Apostolova I,Mathies FL,Frings L,Klutmann S,Hellwig S,Meyer PT,Buchert R

    更新日期：2020-10-31 00:00:00

  • Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.

    abstract：PURPOSE:To assess the radiation dosimetry and biodistribution of (99m)Tc-labeled ethylene dicysteine deoxyglucose ((99m)Tc-EC-DG) in patients with non-small-cell lung cancer (NSCLC). METHODS:Serial whole-body scans were acquired 0, 2, 4, 6 and 24 h after injection of (99m)Tc-EC-DG (925 MBq) in seven NSCLC patients. Ra...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-009-1135-8

    authors： Schechter NR,Erwin WD,Yang DJ,Kim EE,Munden RF,Forster K,Taing LC,Cox JD,Macapinlac HA,Podoloff DA

    更新日期：2009-10-01 00:00:00

  • Radioiodine therapy and thyrostatic drugs and iodine.

    abstract：:Radioiodine therapy is now the most common definite treatment for persistent hyperthyroidism. The outcome of radioiodine therapy depends mainly on the absorbed energy dose in the diseased thyroid tissue. The administered activity and the resulting target dose in the thyroid depend on both the biokinetics of radioiodin...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-002-0868-4

    authors： Moka D,Dietlein M,Schicha H

    更新日期：2002-08-01 00:00:00